Literature DB >> 18591981

The exploration of macrocycles for drug discovery--an underexploited structural class.

Edward M Driggers1, Stephen P Hale, Jinbo Lee, Nicholas K Terrett.   

Abstract

Macrocyclic natural products have evolved to fulfil numerous biochemical functions, and their profound pharmacological properties have led to their development as drugs. A macrocycle provides diverse functionality and stereochemical complexity in a conformationally pre-organized ring structure. This can result in high affinity and selectivity for protein targets, while preserving sufficient bioavailability to reach intracellular locations. Despite these valuable characteristics, and the proven success of more than 100 marketed macrocycle drugs derived from natural products, this structural class has been poorly explored within drug discovery. This is in part due to concerns about synthetic intractability and non-drug-like properties. This Review describes the growing body of data in favour of macrocyclic therapeutics, and demonstrates that this class of compounds can be both fully drug-like in its properties and readily prepared owing to recent advances in synthetic medicinal chemistry.

Mesh:

Substances:

Year:  2008        PMID: 18591981     DOI: 10.1038/nrd2590

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  251 in total

1.  Water-Soluble Palladium Reagents for Cysteine S-Arylation under Ambient Aqueous Conditions.

Authors:  Anthony J Rojas; Bradley L Pentelute; Stephen L Buchwald
Journal:  Org Lett       Date:  2017-08-04       Impact factor: 6.005

2.  Peptide bicycles that inhibit the Grb2 SH2 domain.

Authors:  Justin S Quartararo; Pianpian Wu; Joshua A Kritzer
Journal:  Chembiochem       Date:  2012-06-11       Impact factor: 3.164

3.  Synthesis, molecular docking and biological evaluation as HDAC inhibitors of cyclopeptide mimetics by a tandem three-component reaction and intramolecular [3+2] cycloaddition.

Authors:  Tracey Pirali; Valeria Faccio; Riccardo Mossetti; Ambra A Grolla; Simone Di Micco; Giuseppe Bifulco; Armando A Genazzani; Gian Cesare Tron
Journal:  Mol Divers       Date:  2009-05-28       Impact factor: 2.943

4.  A strategy for the diversity-oriented synthesis of macrocyclic scaffolds using multidimensional coupling.

Authors:  Henning S G Beckmann; Feilin Nie; Caroline E Hagerman; Henrik Johansson; Yaw Sing Tan; David Wilcke; David R Spring
Journal:  Nat Chem       Date:  2013-08-25       Impact factor: 24.427

5.  Enzymology: Modular biosynthesis branches out.

Authors:  Craig A Townsend
Journal:  Nature       Date:  2013-09-18       Impact factor: 49.962

6.  Artificial Macrocycles as IL-17A/IL-17RA Antagonists.

Authors:  Wenjia Wang; Matthew R Groves; Alexander Dömling
Journal:  Medchemcomm       Date:  2017-10-25       Impact factor: 3.597

7.  Template-constrained macrocyclic peptides prepared from native, unprotected precursors.

Authors:  Kenneth V Lawson; Tristan E Rose; Patrick G Harran
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  In Search of the Optimal Macrocyclization Site for Neurotensin.

Authors:  Marc Sousbie; Élie Besserer-Offroy; Rebecca L Brouillette; Jean-Michel Longpré; Richard Leduc; Philippe Sarret; Éric Marsault
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

9.  Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection.

Authors:  Brian N Tse; Thomas M Snyder; Yinghua Shen; David R Liu
Journal:  J Am Chem Soc       Date:  2008-10-29       Impact factor: 15.419

10.  Macrocyclization of the ATCUN motif controls metal binding and catalysis.

Authors:  Kosh P Neupane; Amanda R Aldous; Joshua A Kritzer
Journal:  Inorg Chem       Date:  2013-02-19       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.